A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseases
Smoking is related to worse survival outcomes and higher incidences of liver cirrhosis and CVD in MASLD and MetALD cohorts. Therefore, smoking cessation and prevention are crucial strategies for reducing the burden of liver disease and improving patient prognosis.
Authors
- Ji Won Han (ORCID: https://orcid.org/0000-0003-1456-1450)
- Tom Ryu (ORCID: https://orcid.org/0000-0003-0027-0249)
- Hyun Suk Yang (ORCID: https://orcid.org/0000-0002-7056-3648)
- Beom Sun Chung (ORCID: https://orcid.org/0000-0002-3644-9120)
- Seung Yun Chae (ORCID: https://orcid.org/0000-0002-1807-9461)
- Jae Jun Lee (ORCID: https://orcid.org/0000-0002-5418-500X)
- Keungmo Yang (ORCID: https://orcid.org/0009-0005-0922-6588)
Institutions
- Yonsei University (KR)
- Soonchunhyang University (KR)
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1177/17562848251331315
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.06